Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease which can have a negative impact on the quality of life (QoL). The moderate-to-severe forms frequently require systemic treatment. Dupilumab is a human monoclonal antibody directed against the alpha subunit of the IL-4 receptor. It has been the first biologic drug that approved for the treatment of moderate to severe AD.
Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab / S. Ferrucci, S. Tavecchio, E. Berti, L. Angileri. - In: CLINICAL AND EXPERIMENTAL DERMATOLOGY. - ISSN 0307-6938. - (2020). [Epub ahead of print] [10.1111/ced.14207]
Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab
S. TavecchioSecondo
;E. BertiPenultimo
;L. Angileri
Ultimo
2020
Abstract
Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease which can have a negative impact on the quality of life (QoL). The moderate-to-severe forms frequently require systemic treatment. Dupilumab is a human monoclonal antibody directed against the alpha subunit of the IL-4 receptor. It has been the first biologic drug that approved for the treatment of moderate to severe AD.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Acute onset ced.14207 (1).pdf
Open Access dal 02/03/2021
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
8.16 MB
Formato
Adobe PDF
|
8.16 MB | Adobe PDF | Visualizza/Apri |
|
ced.14207.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
277.55 kB
Formato
Adobe PDF
|
277.55 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
